Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» patent cliff
patent cliff
Pfizer's Heading for a Patent Cliff
Pfizer's Heading for a Patent Cliff
Motley Fool
Pfizer
patents
patent cliff
Flag link:
Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’
Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’
BioPharma Dive
Big Pharma
patents
patent cliff
biosimilars
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Opdivo
Flag link:
In Face of Multiple Patent Cliffs, Novartis' Prostate Cancer Drug Shows Promise
In Face of Multiple Patent Cliffs, Novartis' Prostate Cancer Drug Shows Promise
BioSpace
Novartis
prostate cancer
Pluvicto
clinical trials
patents
patent cliff
Flag link:
AbbVie preps for an onslaught of Humira biosimilars in 2023, with Skyrizi and Rinvoq to fill the gap for now
AbbVie preps for an onslaught of Humira biosimilars in 2023, with Skyrizi and Rinvoq to fill the gap for now
Endpoints
AbbVie
Humira
patents
biosimilars
earnings
patent cliff
Flag link:
Amgen, on an M&A spree, inks $3.7B ChemoCentryx buyout to boost inflammatory disease presence
Amgen, on an M&A spree, inks $3.7B ChemoCentryx buyout to boost inflammatory disease presence
Fierce Pharma
Amgen
M&A
patent cliff
ChemoCentryx
Flag link:
Why Regeneron Investors Shouldn't Fear Its Patent Cliff
Why Regeneron Investors Shouldn't Fear Its Patent Cliff
Motley Fool
Regeneron
patents
patent cliff
Eylea
Flag link:
The patent winter is coming
The patent winter is coming
EP Vantage
patents
biosimilars
patent cliff
Keytruda
Opdivo
Eliquis
Darzalex
Revlimid
Humira
Stelara
AbbVie
Merck
Bristol Myers Squibb
JNJ
Flag link:
'We need to do more': Merck CEO Rob Davis highlights M&A, deals strategy ahead of '28 Keytruda patent cliff
'We need to do more': Merck CEO Rob Davis highlights M&A, deals strategy ahead of '28 Keytruda patent cliff
Endpoints
Merck
Pharma CEOs
Rob Davis
M&A
Keytruda
patent cliff
Flag link:
Merck’s Davis Looking to Diversify in Preparation for Keytruda Patent Cliff
Merck’s Davis Looking to Diversify in Preparation for Keytruda Patent Cliff
BioSpace
Merck
Keytruda
patents
patent cliff
cancer
Rob Davis
Flag link:
The top 15 blockbuster patent expirations coming this decade
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
Flag link:
Will the COVID Vaccine Companies Fall off the Patent Cliff?
Will the COVID Vaccine Companies Fall off the Patent Cliff?
Motley Fool
vaccines
COVID-19
patents
patent cliff
Flag link:
This Is Why Humira Isn't AbbVie's Biggest Problem Right Now
This Is Why Humira Isn't AbbVie's Biggest Problem Right Now
Motley Fool
AbbVie
Humira
patents
patent cliff
Imbruvica
Flag link:
Second Patent Cliff Lies Ahead for Pharma With $251 Billion in Sales at Risk by 2024
Second Patent Cliff Lies Ahead for Pharma With $251 Billion in Sales at Risk by 2024
Center for Biosimilars
biosimilars
patent cliff
generics
Flag link:
Bristol-Myers Squibb nixes 58 marketing jobs as HIV medications near patent cliff
Bristol-Myers Squibb nixes 58 marketing jobs as HIV medications near patent cliff
Fierce Pharma
Bristol-Myers Squibb
HIV
layoffs
patent cliff
Reyataz
Sustiva
Flag link:
Why Drugmakers Aren’t Sweating the Next Wave of Patent Losses
Why Drugmakers Aren’t Sweating the Next Wave of Patent Losses
Bloomberg
patents
Roche
Sanofi
Eli Lilly
patent cliff
Flag link:
Crestor tumbles off patent cliff as first generic copy approved in US
Crestor tumbles off patent cliff as first generic copy approved in US
BioPharma Dive
Crestor
patents
patent cliff
generics
AstraZeneca
Watson Pharmaceuticals
Flag link:
40% Of Amgen Sales Are Due To Fall Off The Patent Cliff
40% Of Amgen Sales Are Due To Fall Off The Patent Cliff
Seeking Alpha
Amgen
patents
patent cliff
Flag link:
Why the Patent Cliff Is a Key Driver of Generic Drug Growth
Why the Patent Cliff Is a Key Driver of Generic Drug Growth
Yahoo/Market Realist
patents
patent cliff
generics
Flag link:
Gilead Sciences: Patent Cliff? What Patent Cliff?
Gilead Sciences: Patent Cliff? What Patent Cliff?
Barron's
Gilead Sciences
patent cliff
patents
Genvoya
Flag link:
The Coming Drug-Patent Cliff Is Pushing This Portfolio Up
The Coming Drug-Patent Cliff Is Pushing This Portfolio Up
Yahoo/Benzinga
patents
patent cliff
Flag link:
Pages
1
2
3
next ›
last »